Related Experiment Videos
Unaltered lymphocyte beta-adrenoceptor responsiveness in hyperthyroidism and hypothyroidism
Clinical Pharmacology and Therapeutics
|March 1, 1981
Summary
Thyroid disease does not alter beta-adrenoceptor sensitivity in lymphocytes. Studies show lymphocyte beta 2-adrenoceptor responses remain unchanged in hyperthyroidism and hypothyroidism.
Area of Science:
- Endocrinology
- Cellular Biology
- Pharmacology
Background:
- Beta-adrenoceptor sensitivity is potentially affected by thyroid dysfunction.
- Thyrotoxicosis (hyperthyroidism) and myxedema (hypothyroidism) represent extremes of thyroid hormone levels.
Purpose of the Study:
- To investigate the impact of hyperthyroidism and hypothyroidism on beta-adrenoceptor sensitivity.
- To compare lymphocyte responses to beta-adrenergic stimulation in patients with and without thyroid disease.
Main Methods:
- Studied peripheral blood lymphocytes from patients with thyrotoxicosis, myxedema, and healthy controls.
- Stimulated lymphocytes with varying concentrations of (-)-isoproterenol to assess cyclic adenosine monophosphate (cAMP) production.
- Analyzed dose-response curves, maximum velocity (Vmax), and half-maximum effective concentration (EC50).
Main Results:
- Lymphocyte basal cAMP concentrations were elevated in untreated thyrotoxicosis compared to controls and untreated myxedema.
- No significant differences were observed in the full isoproterenol dose-response curves across all groups.
- Calculated Vmax and EC50 values for cAMP production were similar in patients with thyroid disease and controls.
Conclusions:
- Lymphocyte beta 2-adrenoceptor responses to isoproterenol stimulation are not significantly altered in hyperthyroidism or hypothyroidism.
- Basal cAMP levels may differ, but the functional sensitivity of beta-adrenoceptors remains intact in these thyroid states.